Clinical Trial: Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07631806) titled 'Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data' on June 02.

Brief Summary: This project aims to develop a precision screening and diagnostic solution for prostate cancer based on multimodal artificial intelligence, focusing on addressing the diagnostic challenge in patients within the PSA "gray zone" of 4-10 ng/mL. The project will integrate multidimensional information including ctDNA liquid biopsy, routine laboratory data, and prostate ultrasound images to develop three models: a ctDNA-based multimodal AI prediction model, a routine laboratory data-assisted decision model, and an ultrasoun...